BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31915870)

  • 1. [Acne inversa (hidradenitis suppurativa)].
    Iesalnieks I; Dornseifer U
    Chirurg; 2020 Apr; 91(4):293-300. PubMed ID: 31915870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis suppurativa (acne inversa): management of a recalcitrant disease.
    Lam J; Krakowski AC; Friedlander SF
    Pediatr Dermatol; 2007; 24(5):465-73. PubMed ID: 17958790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of acne inversa].
    Schneider-Burrus S; Arpa E; Kors C; Stavermann T; Sabat R; Kokolakis G
    Hautarzt; 2018 Jan; 69(1):58-63. PubMed ID: 29234829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CME Dermatology 23: Hidradenitis suppurativa].
    Dahmen RA; Lautenschlager S
    Praxis (Bern 1994); 2021; 110(7):363-372. PubMed ID: 34019444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hidradenitis suppurativa - symptoms, diagnostics, and therapy].
    Arenbergerová M; Dahmen RA; Arenberger P
    Cas Lek Cesk; 2017; 156(3):127-132. PubMed ID: 28722455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOSS OF EFFICACY OF ADALIMUMAB IN HIDRADENITIS SUPPURATIVA: FOCUS ON ALTERNATIVES.
    Tchernev G
    Georgian Med News; 2023; (340-341):297-300. PubMed ID: 37805915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.
    Zouboulis CC; Bechara FG; Fritz K; Goebeler M; Hetzer FH; Just E; Kirsten N; Kokolakis G; Kurzen H; Nikolakis G; Pinter A; Podda M; Rosinski K; Schneider-Burrus S; Taube KM; Volz T; Winkler T; Kristandt A; Presser D; Zouboulis VA
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):868-889. PubMed ID: 38770982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Therapeutic Approaches and Targets for the Treatment of Hidradenitis Suppurativa.
    Giuffrida R; Cannavò SP; Coppola M; Guarneri C
    Curr Pharm Biotechnol; 2021; 22(1):59-72. PubMed ID: 32368973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hidradenitis suppurativa /acne inversa-surgical options, reconstruction and combinations with drug therapies-an update].
    Cramer P; Schneider-Burrus S; Kovács M; Scholl L; Podda M; Bechara FG
    Hautarzt; 2021 Aug; 72(8):692-699. PubMed ID: 34228137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Microbiology of Hidradenitis Suppurativa.
    Ring HC; Emtestam L
    Dermatol Clin; 2016 Jan; 34(1):29-35. PubMed ID: 26617355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment?
    Bettoli V; Zauli S; Virgili A
    G Ital Dermatol Venereol; 2016 Apr; 151(2):216-8. PubMed ID: 27068603
    [No Abstract]   [Full Text] [Related]  

  • 14. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa in patients of paediatric age: a pilot prospective study.
    Bettoli V; Toni G; Odorici G; Forconi R; Corazza M
    Br J Dermatol; 2021 Jul; 185(1):216-217. PubMed ID: 33544882
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment options in severe hidradenitis suppurativa].
    Mooij JE; van't Oost L; Leenarts MF; Mekkes JR
    Ned Tijdschr Geneeskd; 2011; 155():A1912. PubMed ID: 21426594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CME Dermatology 23/Answers: Hidradenitis suppurativa].
    Dahmen RA; Lautenschlager S
    Praxis (Bern 1994); 2021 Jun; 110(8):471-472. PubMed ID: 34107755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hidradenitis suppurativa].
    Tolaas E; Knudsen CW; Sviland L; Tønseth KA
    Tidsskr Nor Laegeforen; 2009 May; 129(10):992-6. PubMed ID: 19448752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acne inversa (alias hidradenitis suppurativa).
    Jansen I; Altmeyer P; Piewig G
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):532-40. PubMed ID: 11843212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis Suppurativa: Rapid Evidence Review.
    Wipperman J; Bragg DA; Litzner B
    Am Fam Physician; 2019 Nov; 100(9):562-569. PubMed ID: 31674740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.